$3.25
-0.28-7.93%
Last update: Nov 6, 4:00 PM
TriSalus Life Sciences Inc
TLSINASDAQ
The average analyst price target for TriSalus Life Sciences is $10.72, 229.8% above the current price. Of 8 analysts, 8 rate it Buy. Targets range from $7 to $16. The latest change came on Sep 23, 2026, when HC Wainwright & Co. raised its price target on TriSalus Life Sciences from $11 to $12 and kept a Buy rating.
Price Target Range — 8 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
